[Thyroid malignant lymphoma]

Nihon Rinsho. 2006 May 28:Suppl 1:482-4.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Cytodiagnosis
  • Doxorubicin / administration & dosage
  • Humans
  • Lymphoma* / classification
  • Lymphoma* / diagnosis
  • Lymphoma* / pathology
  • Lymphoma* / therapy
  • Neoplasm Staging
  • Prednisolone / administration & dosage
  • Prognosis
  • Radiotherapy
  • Rituximab
  • Thyroid Gland / diagnostic imaging
  • Thyroid Gland / pathology
  • Thyroid Neoplasms* / classification
  • Thyroid Neoplasms* / diagnosis
  • Thyroid Neoplasms* / pathology
  • Thyroid Neoplasms* / therapy
  • Ultrasonography
  • Vincristine / administration & dosage

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisolone

Supplementary concepts

  • VAP-cyclo protocol